题名 |
Difference in the Prevalence of CYP2C19 Poor Metabolizers among Racial and Ethnic Groups of Eastern Taiwan |
并列篇名 |
東台灣不同族群間在CYP2C19慢代謝者盛行率上存在差異 |
DOI |
10.6557/GJT.201312_30(4).0002 |
作者 |
陳明杰(Ming-Cheh Chen);易志勳(Chih-Hsun Yi);王豊裕(Li-Yu Wang);林憲宏(Hans Hsien-Hong Lin);胡志棠(Chi-Tan Hu) |
关键词 |
CYP2C19多態性 ; 慢代謝者基因型 ; 東台灣 ; 族群 ; 藥理基因學差異 ; CYP2C19 Polymorphism ; poor metabolizer genotypes ; Eastern Taiwan ; ethnic groups ; pharmacogenetic difference |
期刊名称 |
臺灣消化醫學雜誌 |
卷期/出版年月 |
30卷4期(2013 / 12 / 01) |
页次 |
300 - 308 |
内容语文 |
英文 |
中文摘要 |
Background: CYP2C19 is an enzyme for drug metabolism, and its genetic polymorphisms produce interpersonal variations in drug responses. The two major loss-of-function alleles for poor metabolizers (PMs) for Asian populations were CYP2C19*2 and CYP2C19*3. This study was conducted to assess whether the prevalence of CYP2C19 PM genotypes differs between Han Chinese and Taiwan Aborigines in Eastern Taiwan.Material and Methods: A total of 955 students were selected from six senior high schools in Hualien County, and 938 (98.2%) of them were genotyped for CYP2C19*2 and CYP2C19*3 by direct sequencing method. Individuals with homozygous CYP2C19*2, homozygous CYP2C19*3 or heterozygous CYP2C19*2/*3 were predicted to have the PM phenotype.Results: The prevalence of CYP2C19*2 and CYP2C19*3 in Taiwan Aborigines were higher than those in Han Chinese (40.1% and 9.1% vs. 30.6% and 5.5%, both p < 0.01). The predicted CYP2C19 PM phenotype in Taiwan Aborigines was also higher (23.3% vs. 13.0%, p < 0.01).Conclusion: We showed there are major differences in the prevalences of CYP2C19 PMs among different ethnic groups in Eastern Taiwan. |
英文摘要 |
Background: CYP2C19 is an enzyme for drug metabolism, and its genetic polymorphisms produce interpersonal variations in drug responses. The two major loss-of-function alleles for poor metabolizers (PMs) for Asian populations were CYP2C19*2 and CYP2C19*3. This study was conducted to assess whether the prevalence of CYP2C19 PM genotypes differs between Han Chinese and Taiwan Aborigines in Eastern Taiwan.Material and Methods: A total of 955 students were selected from six senior high schools in Hualien County, and 938 (98.2%) of them were genotyped for CYP2C19*2 and CYP2C19*3 by direct sequencing method. Individuals with homozygous CYP2C19*2, homozygous CYP2C19*3 or heterozygous CYP2C19*2/*3 were predicted to have the PM phenotype.Results: The prevalence of CYP2C19*2 and CYP2C19*3 in Taiwan Aborigines were higher than those in Han Chinese (40.1% and 9.1% vs. 30.6% and 5.5%, both p < 0.01). The predicted CYP2C19 PM phenotype in Taiwan Aborigines was also higher (23.3% vs. 13.0%, p < 0.01).Conclusion: We showed there are major differences in the prevalences of CYP2C19 PMs among different ethnic groups in Eastern Taiwan. |
主题分类 |
醫藥衛生 >
內科 |